MARKET

LBRX

LBRX

LB Pharmaceuticals
NASDAQ
46.36
-1.31
-2.75%
Opening 12:24 09/10 EDT
OPEN
47.20
PREV CLOSE
47.67
HIGH
47.20
LOW
45.50
VOLUME
73.25K
TURNOVER
--
52 WEEK HIGH
50.16
52 WEEK LOW
13.36
MARKET CAP
1.50B
P/E (TTM)
-15.5524
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LBRX last week (0831-0904)?
Weekly Report · 3d ago
LB Pharmaceuticals Names Joseph Miller Chief Financial Officer
Dow Jones · 09/03 12:43
LB Pharmaceuticals Appoints Joseph Miller CFO
Benzinga · 09/03 12:07
Press Release: LB Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer
Dow Jones · 09/03 12:00
Weekly Report: what happened at LBRX last week (0824-0828)?
Weekly Report · 08/31 09:49
Analog Devices To Rally Around 81%? Here Are 10 Top Analyst Forecasts For Monday
Benzinga · 08/24 13:30
LB Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 08/24 10:16
LB Pharmaceuticals Price Target Raised to $60.00/Share From $45.00 by HC Wainwright & Co.
Dow Jones · 08/24 10:16
More
About LBRX
LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. The Company is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a Phase III-ready oral, small molecule for the treatment of acute schizophrenia, defined as a sudden and severe episode of psychotic symptoms, characterized by hallucinations, delusions, and other positive symptoms. The Company is also developing a long-acting injectable, or LAI, formulation of LB-102, which improves compliance, a common issue in patients with schizophrenia and bipolar disorder.

Webull offers LB Pharmaceuticals Inc stock information, including NASDAQ: LBRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LBRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LBRX stock methods without spending real money on the virtual paper trading platform.